Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 1.6. It has been cited 65 times, with 55 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.628
From this paper's citation signal
Citation Network Contribution
0.939
From 40 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 55 citers.
NIAID NIH HHS
Grant: R01 AI133822
NIAID NIH HHS
Grant: R03 AI166285
NIAID NIH HHS
Grant: R56 AI109294
National Institutes of Health
Grant: 5R01AI133822-03
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory Activity
National Institutes of Health
Grant: 1R03AI166285-01A1
Development of an acute myeloid leukemia murine model of invasive pulmonary aspergillosis to gain insights into the role of leukemia and its treatments in the pathobiology of aspergillosis
National Institutes of Health
Grant: 2R56AI109294-06A1
Regulation and function of nonlymphoid organ CD103+ dendritic cells
National Institute of Allergy and Infectious Diseases
University of Texas MD Anderson Cancer Center
FWCI
5.04
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals